World's leading clinical conference on bone, joint and muscle health
Programme
Thursday May 4th - CEST Time zone
01:00 - 23:59
WCO-IOF-ESCEO
16:20 - 16:50
Auditorium B
PRE-CONGRESS SESSION
World Health Organization five-year project to improve the management of osteoporosis around the globe: A partnership with ESCEO, under the auspices of the World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
(Jointly organized by the WHO CC and by ESCEO. This session is organized independently of the WCO 2023)
Chairpersons :
Jean-Yves Reginster
& René Rizzoli
- Presentation of the Islene Araujo de Carvalho-ESCEO 2023 Prize
- WHO Bone Health Expert Working Group: A WHO initiative to provide scientific guidance on the screening, diagnosis and management of osteoporosis around the globe.
- The five-year partnership between ESCEO and WHO: Unique opportunity to improve the well-being of osteoporotic patients.
- The five-year partnership between ESCEO and WHO: How can a scientific society help WHO in its goals and missions to improve healthy aging.
17:00 - 19:30
Auditorium B
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons :
Stefania Maggi
& Cyrus Cooper
17:00
Auditorium B
Opening of the meeting
17:15
Auditorium B
Best clinical papers published in 2022
18:00
Auditorium B
Can we walk after a medullary section?
18:30
Auditorium B
An update on FRAX and potential clinical adjustments
18:45
Auditorium B
Presentation of the IOF President's Award
19:00
Auditorium B
Touching the stars: a warm welcome from ESA Astronaut Samantha Cristoforetti
19:10
Auditorium B
Presentation of the 2023 ESCEO Medal of Excellence
19:20
Auditorium B
Presentation of the 2023 IOF CSA Medal of Achievement
19:30 - 20:30
Banquet Hall
Welcome Cocktail offered by ESCEO and IOF
Friday May 5th - CEST Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 123
Capture the Fracture® - Advocating for effective and sustainable strategies for secondary fracture prevention
Chairperson :
Nicholas Harvey
- The role of orthopaedic surgeon in the FLS
- 20 years of experiences with an FLS
- Running an FLS is cost-effective
- Running an FLS is not only reducing fractures, but also reduces mortality
- Panel discussion
08:00
Room 129
Capture the Fracture mentorship – global delivery and what we have learnt
Chairperson :
Kassim Javaid
- Overview and progress
- The Role of the IOF Coordinator
- Country specific outcomes / resources/ events : LATAM
- Country specific outcomes / resources/ events : Europe
- Country specific outcomes / resources/ events : APAC
- Panel Discussion – How to improve mentorship for the future
08:00
Room 130
Non-sponsored symposium of the GRIIP - “PRP in the management of musculoskeletal diseases”
Chairperson :
Jean-François Kaux
- Efficacy of PRP in tendinopathies
- Standardisation of PRP in the management of knee and hip osteoarthritis
- Future perspectives for the use of PRP in the management of musculoskeletal disorders
08:00
Room 122
Osteoporosis and life: from childhood to aging
Chairperson :
Juan Jose Scali
- Introduction to Symposium
- Osteoporosis in childhood and teenagers
- Osteoporosis in reproductive life
- Osteoporosis in aged: What we know and what we need to know?
- Questions and comments from the audience
08:00
Room 120
Challenging decisions in Osteoporosis Management
Chairpersons :
Yasser El Miedany
& Naglaa Gadallah
- Osteoporosis case ascertainment strategies: North Africa Experience
- DXA scan: Beyond BMD measurement
- Management of osteoporosis before the age of 50
08:00
Room 118
Diabetes, Obesity bone and fractures. Myths and Pearls.
Chairpersons :
Peter Ebeling
, Sonia Cerdas Perez
& Jose Luis Neyro Bilbao
- Diabetes and bone metabolism
- Obesity, bone metabolism, osteoporosis and fractures
08:00
Room 133-134
Accelerating musculoskeletal healthcare into the 21st century: Insights to real-world implementation of digital health technologies for osteoporosis, sarcopenia, falls and fractures.
Chairperson :
Mylene Aubertin-Leheudre
- Going digital – The role of digital health technologies for geriatric assessments and the remote delivery and monitoring of exercise and lifestyle interventions for older adults
- Digital voice assistants: A novel technological approach to supporting older adults to self-manage musculoskeletal conditions
- Social disadvantage and musculoskeletal health: Ensuring that the ‘digital divide’ does not impact on the equitable delivery of care
08:00
Room 121
Physical activity and exercise in mild cognitive impairment and dementia: guidelines from European societies
Chairperson :
Olivier Bruyère
- Physical activity and exercise for the prevention of dementia
- Importance of physical activity and exercise in mild cognitive impairment
- Physical activity and exercise in mild cognitive impairment and dementia: guidelines from European societies
08:00
Room 119
The influence of exercise on the chronic low-grade inflammatory profile
Chairperson :
Ivan Bautmans
- Strength training alters lps-induced immune responses in peripheral mononuclear blood cells of older persons
- Three months of resistance training alters the expression of inflammation related genes in PBMCS with a LPS challenge
- Is physical activity associated with pre-frailty, T-cell phenotypes and inflammation in the oldest old?
- Effects of daily immunonutrient intake on inflammation and sarcopenia: Role of physical activty
- Intra-articular biomarkers and characteristics of pain sensitization: How are they related to each other in knee osteoarthritis patients?
- Can exercise therapy influence inflammatory markers and BDNF in patients with knee osteoarthritis? A systematic review with meta-analysis
- Discussion
08:00 - 09:00
Auditorium B
Sponsored Breakfast Satellite Symposium
09:00 - 10:30
Auditorium A
Scientific Session I
Chairpersons :
Bess Dawson-Hughes
& Philippe Halbout
09:00
Auditorium A
Plenary Lecture 1
To treat or not to treat: Continuous or intermittent therapies in osteoporosis
09:30
Auditorium A
Oral communication selected from abstracts
OC1: ONE YEAR OF ROMOSOZUMAB FOLLOWED BY ONE YEAR OF DENOSUMAB VERSUS TWO YEARS OF DENOSUMAB: BMD AND FRACTURE RESULTS FROM THE FRAME AND FRAME EXTENSION STUDIES
Presenting author:
Authors:
09:40
Auditorium A
Oral communication selected from abstracts
OC2: EFFECTIVENESS OF ASFOTASE ALFA FOR TREATMENT OF ADULTS WITH HYPOPHOSPHATASIA: RESULTS FROM A GLOBAL REGISTRY
Presenting author:
Authors:
09:50
Auditorium A
Oral communication selected from abstracts
OC3: PRE-TREATMENT LEVEL OF BONE TURNOVER DOES NOT INFLUENCE THE RESPONSE TO ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS. A LARGE HISTOMORPHOMETRIC STUDY
Presenting author:
Authors:
10:00
Auditorium A
Oral communication selected from abstracts
OC4: EFFICACY AND SAFETY OF PROPOSED DENOSUMAB BIOSIMILAR AND REFERENCE DENOSUMAB IN POSTMENOPAUSAL OSTEOPOROSIS AT 52 WEEKS: THE ROSALIA STUDY
Presenting author:
Authors:
10:10
Auditorium A
Oral communication selected from abstracts
OC5: COST-EFFECTIVENESS OF ABALOPARATIDE FOLLOWED BY ALENDRONATE IN US WOMEN AND MEN AT HIGH RISK OF OSTEOPOROTIC FRACTURES
Presenting author:
Authors:
10:20
Auditorium A
Oral communication selected from abstracts
OC6: COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE U.S. MEDICARE PROGRAM
Presenting author:
Authors:
10:30 - 12:10
Auditorium A
Scientific Session II
Chairpersons :
John A. Kanis
& Charlotte Beaudart
10:30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
10:40
Auditorium A
Plenary Lecture 2
Should the punishment fit the crime? Osteoporosis treatment in relation to fracture risk
11:20
Auditorium A
Oral communication selected from abstracts
OC7: SINGLE WOMEN SHOW HIGHER FRACTURE RATES AND DIFFERENT ANTHROPOMETRIC, SOCIOECONOMIC AND LIFESTYLE PROFILES RELATIVE TO THEIR COUNTERPARTS IN RELATIONSHIPS: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
11:30
Auditorium A
Oral communication selected from abstracts
OC8: ADJUSTING CONVENTIONAL FRAX ESTIMATES OF FRACTURE PROBABILITY ACCORDING TO THE NUMBER OF PRIOR FRACTURES
Presenting author:
Authors:
11:40
Auditorium A
Oral communication selected from abstracts
OC9: FRACTURE PATTERNS IN T1D AND THEIR ASSOCIATED RISK FACTORS – A RETROSPECTIVE COHORT STUDY
Presenting author:
Authors:
11:50
Auditorium A
Oral communication selected from abstracts
OC10: TYPE 1 AND 2 DIABETES MELLITUS AND INCIDENT FRACTURE RISK IN UK BIOBANK: IMPACT OF DISEASE TYPE, DURATION AND MICROVASCULAR COMPLICATIONS
Presenting author:
Authors:
12:00
Auditorium A
Sponsored session
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium
12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium
13:45 - 14:00
Podium
IOF Young Investigator Nutrition Research Grants Ceremony
14:00 - 15:00
Meet-The-Expert Session
14:00
Room 121
Disorders of phosphate homeostasis
14:00
Room 120
Sport : how much is too much?
14:00
Room 119
Post-fracture management
14:00
Room 133-134
New guidelines on the management of primary hyperparathyroidsm
14:00 - 15:00
Poster Area
Poster Viewing Session I
14:00 - 15:10
Podium
Oral presentation of selected posters
Chairperson :
Elaine Dennison
14:00
Podium
P506
HAND GRIP STRENGTH TEST AND SHORT PHYSICAL PERFORMANCE BATTERY VERSUS FRAX®: WHICH CORRELATION IN THE FRACTURE RISK? A MACHINE LEARNING STUDY
Presenting author:
Authors:
14:07
Podium
P168
DIGITAL VOICE ASSISTANTS FOR DELIVERING EXERCISE, NUTRITION AND MEDICATION INFORMATION TO POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: A 24-WEEK PILOT RANDOMISED CONTROLLED TRIAL
Presenting author:
Authors:
14:14
Podium
P220
TREATMENT GAP AFTER OSTEOPOROTIC FRAGILITY FRACTURES - A REGIONAL ANALYSIS IN GERMANY
Presenting author:
Authors:
14:21
Podium
P258
ZOLEDRONIC ACID AFTER SPINAL CORD INJURY MITIGATES LOSSES IN PROXIMAL FEMORAL STRENGTH: A POST-HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
Presenting author:
Authors:
14:28
Podium
P264
A PHASE 1, OPEN-LABEL, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALXN1850 IN ADULTS WITH HYPOPHOSPHATASIA
Presenting author:
Authors:
14:35
Podium
P290
EXECUTIVE FUNCTION AND INTELLIGENCE: ASSOCIATIONS WITH BONE SIZE AND MINERAL DENSITY IN CHILDHOOD
Presenting author:
Authors:
14:42
Podium
P403
A PROSPECTIVE STUDY TO EVALUATE PATIENT-REPORTED QUALITY OF LIFE PRIOR TO AND AFTER ASFOTASE ALFA TREATMENT IN ADULTS WITH PEDIATRIC-ONSET HYPOPHOSPHATASIA
Presenting author:
Authors:
14:49
Podium
P416
MOBILITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH PAEDIATRIC-ONSET HYPOPHOSPHATASIA TREATED WITH ASFOTASE ALFA: INTERIM ANALYSIS FROM THE UK MANAGED ACCESS AGREEMENT
Presenting author:
Authors:
14:56
Podium
P511
ISCHEMIC STROKE IS ASSOCIATED WITH REDUCED SCLEROSTIN EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES
Presenting author:
Authors:
15:03
Podium
P609
EFFECTS OF PARATHYROIDECTOMY ON RISK OF FRACTURE BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY
Presenting author:
Authors:
14:00 - 15:00
Room 131-132
Special Educational Lecture
Assessment of quality of life: state of the art
14:00 - 15:00
Room 118
ESCEO-OARSI Symposium - Why or why not osteoporosis medications work for osteoarthritis?
Chairpersons :
Jean-Yves Reginster
& Gun-il Im
- Introduction
- Impact of anti-osteoporosis medications on pre-clinical models of osteoarthritis
- Outcomes of clinical trials having assessed anti-osteoporosis drugs in osteoarthritis
- Why did the studies assessing anti-osteoporosis drugs in osteoarthritis fail?
- Subchondral bone as a target for anti-osteoarthritis medications: how can we identify the most appropriate patients to be included in clinical trials?
14:00 - 15:00
Room 130
ESCEO SYMPOSIUM - Recommendations for the selection of biochemical markers of musculoskeletal health and aging to be assessed in clinical trials of drugs aiming at the management of sarcopenia
Chairpersons :
Etienne Cavalier
& René Rizzoli
- Introduction
- Why do we need biomarkers in sarcopenia research?
- Which biomarkers for which studies
14:00 - 15:00
Room 123
Sponsored Meet-The-Expert Session
14:00 - 15:00
Room 122
Update on the use of TBS in the management of osteoporosis: Working Group organized by ESCEO and IOF under the auspices of the WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
Chairpersons :
Olivier Lamy
& Nicholas Harvey
- New insight on the use of TBS in clinical practice
- Role of TBS in the management of osteoporosis
- Discussion - Doctor Sansin Tuzun (Leader)
15:00 - 17:00
Auditorium A
Scientific Session III
Chairpersons :
Nicholas Harvey
& Ngozi Njeze
15:00
Auditorium A
Plenary Lecture 3
Obesity, weight loss and bone health: what risk and which fractures?
15:30
Auditorium A
Oral communication selected from abstracts
OC11: HEALTH-RELATED QUALITY OF LIFE IN SARCOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author:
Authors:
15:40
Auditorium A
Oral communication selected from abstracts
OC12: DYNAPENIC ABDOMINAL OBESITY AND SUSCEPTIBILITY TO FALL: A PROSPECTIVE ANALYSIS OF THE OSTEOARTHRITIS INITIATIVE
Presenting author:
Authors:
15:50
Auditorium A
Oral communication selected from abstracts
OC13: SARCOPENIA DEFINITIONS AND THEIR ASSOCIATION WITH FRACTURE RISK IN OLDER SWEDISH WOMEN. THE SAHLGRENSKA UNIVERSITY HOSPITAL PROSPECTIVE EVALUATION OF RISK OF BONE FRACTURES (SUPERB) STUDY
Presenting author:
Authors:
16:00
Auditorium A
Oral communication selected from abstracts
OC14: PREDICTORS OF 8-YEAR SURVIVAL IN NURSING HOMES: RESULTS FROM THE SENIOR COHORT.
Presenting author:
Authors:
16:10
Auditorium A
Oral communication selected from abstracts
OC15: THE ASSOCIATIONS BETWEEN OSTEOSARCOPENIA AND FALLS, FRACTURES, AND FRAILTY IN OLDER ADULTS: RESULTS FROM THE CANADIAN LONGITUDINAL STUDY ON AGING (CLSA)
Presenting author:
Authors:
16:20
Auditorium A
Oral communication selected from abstracts
OC16: MUSCLE SIZE AND DENSITY ARE INDEPENDENTLY ASSOCIATED WITH DEATH AFTER HIP FRACTURE: A PROSPECTIVE COHORT STUDY
Presenting author:
Authors:
16:30
Auditorium A
Plenary Lecture 4
Bone: an affair of the heart or of the brain?
15:00 - 16:45
Room 131-132
Committee of National Societies Special Plenary Session
Progress in osteoporosis and fragility fracture management around the world
Chairpersons :
Jean-Yves Reginster
& Famida Jiwa
15:03
Room 131-132
OCs1: APPLICATION OF DEEP LEARNING ALGORITHM TO DETECT AND VISUALIZE VERTEBRAL FRACTURES ON PLAIN FRONTAL RADIOGRAPHS
Presenting author:
Authors:
15:11
Room 131-132
OCs2: ASSESSMENT OF MACHINE LEARNING MODELS FOR FRACTURE RISK PREDICTION
Presenting author:
Authors:
15:19
Room 131-132
OCs3: SCREENING FOR SARCOPENIA IN OLDER COMMUNITY-DWELLING ADULTS: FINDINGS FROM SOUTHAMPTON LONGITUDINAL STUDY OF AGEING (SALSA)
Presenting author:
Authors:
15:27
Room 131-132
OCs4: PATIENTS’ PREFERENCES FOR COMMUNICATING FRACTURE RISK: THE RISK COMMUNICATION IN OSTEOPOROSIS (RICO) STUDY
Presenting author:
Authors:
15:35
Room 131-132
OCs5: SHORT-TERM (2-YEARS) FRACTURE RISK PREDICTION: A MACHINE LEARNING APPROACH
Presenting author:
Authors:
15:45
Room 131-132
Presentation of the IOF Committee of National Societies Medal
15:50
Room 131-132
Presentation of the ESCEO-Aging Clinical and Experimental Research, Stefania Maggi Prize
15:55
Room 131-132
OCs6: APPENDICULAR LEAN MASS AND FAT PERCENTAGES CUTOFF VALUES TO DEFINE SARCOPENIC OBESITY IN UKRAINE COMMUNITY-DWELLING OLDER ADULTS
Presenting author:
Authors:
16:03
Room 131-132
OCs7: THE CONCEPT OF ‘TIME TO FIRST FRACTURE’ IN THE FRISBEE COHORT: ANALYSIS OF RISK FACTORS AND ASSOCIATION WITH ‘IMMINENT FRACTURES’
Presenting author:
Authors:
16:11
Room 131-132
OCs8: APPLICATION OF TOMOSYNTHESIS FOR VERTEBRAL COMPRESSION FRACTURE DIAGNOSIS AND BONE HEALING ASSESSMENT IN FRACTURE LIAISON SERVICES
Presenting author:
Authors:
16:19
Room 131-132
OCs9: THE ASSOCIATION OF REGIONAL BODY MUSCLE MASS AND FATTY LIVER INDEX IN OLDER PEOPLE: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author:
Authors:
16:27
Room 131-132
OCs10: ASSOCIATIONS BETWEEN HEALTH LITERACY AND BONE, MUSCLE, AND PHYSICAL FUNCTION OUTCOMES IN COMMUNITY-DWELLING OLDER ADULTS
Presenting author:
Authors:
16:35
Room 131-132
OCs11: A SYSTEMATIC REVIEW AND CRITICAL APPRAISAL OF QUALITY INDICATORS TO ASSESS OPTIMAL CARE FOR FRAGILITY HIP FRACTURE
Presenting author:
Authors:
17:00 - 18:30
Auditorium A
Sponsored Satellite Symposium
Saturday May 6th - CEST Time zone
08:00 - 09:00
Room 127-128
IOF Session
How IOF can support your efforts in the clinical setting and at the national level
Chairpersons :
Nicholas Harvey
& Leith Zakraoui
- Opening remarks
- IOF operations supporting science, research, education, policy/advocacy
- Benefits of collaborating with IOF at the local level: how the CTF programme has been actively supporting secondary fracture prevention efforts in Spain
- Q&A session
- Closing remarks
08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 119
Implementing Physical activity for older adults at risk in various and specific situations
Chairperson :
Olivier Bruyère
- Implementing physical activity as a care for older adults following in geriatric outpatient clinics
- Implementing physical activity for community-dwelling seniors during isolation periods (e.g. Covid 19 pandemic)
- Implementing physical activity for older adults in nursing homes
08:00
Room 121
Frailty as a cause and a consequence of hip fractures
Chairpersons :
Gustavo Duque
& Carmen Castillo-Gallego
- Identification of frailty in hip fracture patients
- Forestalling progression of frailty perioperatively in hip fracture patients: A review of systemic and individualized approaches
- Frailty in post-hip fracture patients: what should we do?
08:00
Room 122
Antiosteoporosis Medications and Fracture Healing. A review of the evidence and some recommendations
Chairpersons :
Stuart Silverman
& Kristina Akesson
- A brief introduction
- Basics of fracture healing
- Bisphosphonates and fracture healing
- Other Antiosteoporosis agents and fracture healing
- Conclusion
- Question and Answer Session
08:00
Room 129
How to build the case for effective policy change to address the current and future burden of osteoporosis and fragility fractures
Chairperson :
Thierry Thomas
- Opening remarks
- Challenges in current policy and post-fracture care landscape, and the importance of health economics to generate and leverage evidence based data to build the case for policy change
- The Capture the Fracture® initiative : designing policy tools for effective engagement with policymakers
- Panel discussion
08:00
Room 133-134
The Brussels study on the early predictors of frailty: results and future perspectives
Chairperson :
Ivan Bautmans
- Introduction Concept Butterfly
- Muscle endurance & self-perceived fatigue predict decline in gait speed and activities of Daily Living after one year follow-up: results from the BUTTERFLY Study
- The effect of medication causing autonomic dysfunction on incidence frailty in octagenarians
- Impact of Covid-19 on physical activity, fatigue and frailty in community dwelling older adults: a cross sectional study
- The impact of covid-19 lockdown on the Quality of life, meaningful activities, and frailty in community-dwelling octogenarians: A study in Belgium
- Future perspective: Healthy Ageing Centers
- Discussion
08:00
Room 120
Building Communities of Good Practice Globally: The Impact of Bone Health ECHO, Now and Beyond
Chairperson :
Michael Lewiecki
- Introduction and global overview
- Fracture Liaison Service ECHO in the U.S.A.
- National University of Ireland Galway Bone Health TeleECHO
- Bone Health TeleECHO at the American University of Beirut, Lebanon
- Seeking Answers to the challenges in implementing Bone Health TeleECHO in the Asia Pacific
- Q & A - Panel discussion
08:00
Room 130
Skeletal muscle regeneration, fibrosis, and systemic vascular calcifications in Chronic Kidney Disease
Chairpersons :
Maria Coco
& Kwang Chun
- The Role of calciprotein particles in bone function and vascular calcification
- Skeletal muscle dysfunction and sarcopenia in chronic kidney disease
08:00 - 09:00
Auditorium B
Breakfast Symposium
Breakfast Symposium - Bone status assessment with REMS: an update on fracture risk prediction
Chairperson :
Giuseppe Guglielmi
- Introduction
- Fracture risk assessment by REMS in primary and secondary osteoporosis
- REMS for the evaluation of bone Quantity and Quality
- Precision. Repeatability and Diagnostic Accuracy of REMS technology
- REMS employment in clinical routine: the Polish experience
- Take Home Message
08:00 - 09:00
Room 131-132
ESCEO SYMPOSIUM
Update on the role of Vitamin D supplementation in the management of musculoskeletal diseases
Chairperson :
René Rizzoli
- Epidemiology of Vitamin D deficiency
- Vitamin D and musculoskeletal diseases (effects in depleted and repleted populations)
- Discussion
08:00 - 09:00
Room 118
EUGMS-ESCEO Symposium
The 1st World Falls Guidelines: falls and fracture prevention are intertwined
Chairpersons :
Hubert Blain
& Jesper Ryg
- Risk stratification and Exercise to reduce falls and fracture risk: what are the recommendations of the World Falls Guidelines
- Falls prevention at a fracture liaison service: what’s new from the World Falls Guidelines
- Interactive discussion
09:00 - 10:30
Auditorium A
Scientific Session IV
Chairpersons :
Olivier Bruyère
& Claudia Campusano
09:00
Auditorium A
Plenary Lecture 5
Towards a global definition of sarcopenia: Muscle mass, performance and relevant clinical outcomes
09:30
Auditorium A
Oral communication selected from abstracts
OC17: A PHASE 2, 104-WEEK STUDY OF REPEAT LORECIVIVINT INJECTIONS EVALUATING SAFETY, EFFICACY, AND BONE HEALTH UTILIZING QUANTITATIVE COMPUTED TOMOGRAPHY (QCT) IN KNEE OSTEOARTHRITIS (OA-06)
Presenting author:
Authors:
09:40
Auditorium A
Oral communication selected from abstracts
OC18: PREDICTION OF KNEE OSTEOARTHRITIS CARTILAGE VOLUME LOSS OVER TIME WITH BASELINE BONE CURVATURE REGIONS AS THE BIOMARKERS. USAGE OF MACHINE LEARNING
Presenting author:
Authors:
09:50
Auditorium A
Oral communication selected from abstracts
OC19: NEW BIOMARKERS IN HAND OSTEOARTHRITIS: THE MICRO-RNAS
Presenting author:
Authors:
10:00
Auditorium A
Oral communication selected from abstracts
OC20: BURDEN OF OSTEOARTHRITIS IN CHINA FROM 1990 TO 2019 AND PREDICTIONS OF THE BURDEN IN FUTURE 25 YEARS: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019
Presenting author:
Authors:
10:10
Auditorium A
Oral communication selected from abstracts
OC21: FUNCTIONAL PERFORMANCE OUTCOMES AT 1-YEAR FOLLOW-UP AFTER TREATMENT OF KNEE OSTEOARTHRITIS: COMPARISON BETWEEN PLATELET-RICH PLASMA INJECTION AND ORAL PATENTED CRYSTALLINE GLUCOSAMINE SULFATE: PROPENSITY SCORE MATCH PAIR ANALYSIS
Presenting author:
Authors:
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:10
Auditorium A
Scientific Session V
Chairpersons :
Etienne Cavalier
& Maria Luisa Brandi
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award
10:40
Auditorium A
Plenary Lecture 6
How do we predict and prevent falls in older people?
11:10
Auditorium A
Oral communication selected from abstracts
OC22: DIFFERENTIAL EFFECTS ON RISK OF FRACTURE AND DEATH BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC23: THE IMPORTANCE OF RECENT PREVALENT FRACTURE SITE FOR IMMINENT RISK OF FRACTURE – A RETROSPECTIVE, NATIONWIDE COHORT STUDY OF OLDER SWEDISH MEN AND WOMEN
Presenting author:
Authors:
11:30
Auditorium A
Oral communication selected from abstracts
OC24: GEOGRAPHICAL VARIATION IN OSTEOPOROSIS CARE: A LONGITUDINAL ANALYSIS OVER 23 YEARS
Presenting author:
Authors:
11:40
Auditorium A
Oral communication selected from abstracts
OC25: NUMBER OF PRIOR FALLS AND FRACTURE RISK – POTENTIAL ADJUSTMENT OF CONVENTIONAL FRAX PROBABILITIES
Presenting author:
Authors:
11:50
Auditorium A
Oral communication selected from abstracts
OC26: PAIN INCREASES THE RISK FOR SARCOPENIA IN COMMUNITY-DWELLING ADULTS: RESULTS FROM THE ENGLISH LONGITUDINAL STUDY OF AGEING
Presenting author:
Authors:
12:00
Auditorium A
Oral communication selected from abstracts
OC27: POCOSTEO: RAPID, COST-EFFECTIVE AND EASY-TO-USE POINT-OF-CARE (POC) DEVICE FOR EARLY DETECTION AND MONITORING OF OSTEOPOROSIS
Presenting author:
Authors:
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium
12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium
14:00 - 15:00
Meet-The-Expert Session
14:00
Room 121
Management of hypoparathyroidism
14:00
Room 133-134
Osteoporosis treatments and material level properties of bone
14:00
Room 120
Changing the bone paradigm in kidney transplant recipients
14:00
Room 119
Treatments of endometriosis and bone health
14:00 - 15:00
Poster Area
Poster Viewing Session II
14:00 - 15:10
Podium
Oral presentation of selected posters
Chairperson :
Elaine Dennison
14:00
Podium
P687
ASSOCIATIONS BETWEEN GUT MICROBIOTA AND SARCOPENIA OR ITS DEFINING PARAMETERS: A SYSTEMATIC REVIEW
Presenting author:
Authors:
14:07
Podium
P709
PRELIMINARY RESULTS OF THE INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN FIBROUS BONE DYSPLASIA
Presenting author:
Authors:
14:14
Podium
P1030
A NEW TOOL FOR INCIDENT FRACTURE RISK IDENTIFICATION IN MEN: THE REMS-BASED FRAGILITY SCORE (FS)
Presenting author:
Authors:
14:21
Podium
P1033
EFFECT OF VITAMIN D3, OMEGA-3S AND A SIMPLE HOME EXERCISE PROGRAM ON BMD IN EUROPEAN OLDER ADULTS: THE DO-HEALTH RANDOMIZED CONTROLLED TRIAL
Presenting author:
Authors:
14:28
Podium
P340
A PLACEBO-CONTROLLED, SINGLE BLIND EXTENSION STUDY (OA-07) EVALUATING THE SAFETY AND EFFICACY OF LORECIVIVINT IN SUBJECTS WITH SEVERE OSTEOARTHRITIS OF THE KNEE: RADIOGRAPHIC AND PAIN OUTCOMES AT 24 AND 30 MONTHS
Presenting author:
Authors:
14:35
Podium
P253
DYNAPENIA, LOW MUSCLE MASS OR SARCOPENIA: WHICH BEST PREDICTS MOBILITY DECLINE IN OLDER WOMEN WITH NORMAL GAIT SPEED?
Presenting author:
Authors:
14:42
Podium
P381
SARCOPENIA PREVALENCE, INCIDENCE, AND ASSOCIATION WITH 6 YEARS INCIDENT FRAGILITY FRACTURES IN SWISS POSTMENOPAUSAL WOMEN
Presenting author:
Authors:
14:49
Podium
P460
ASSOCIATION BETWEEN POLLUTION AND FRAILTY IN OLDER PEOPLE: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK
Presenting author:
Authors:
14:56
Podium
P453
DEVELOPMENT OF TWO INNOVANT PERFORMANCE-BASED OBJECTIVE MEASURES IN FELINE OSTEOARTHRITIS: THEIR RELIABILITY AND RESPONSIVENESS TO ANALGESIC TREATMENT
Presenting author:
Authors:
15:03
Podium
P498
DEVELOPMENT AND VALIDATION OF NEW EXERCISES TO PROMOTE PHYSICAL ACTIVITY IN NURSING HOME SETTINGS, THROUGH QUALITATIVE METHOD
Presenting author:
Authors:
14:00 - 15:00
Room 131-132
Special Educational Lecture
Osteoporosis - personalized management
14:00 - 15:00
Room 122
Evidence-based and patient-centered recommendations for the treatment of osteoporosis in men: Outcomes of an ESCEO Working Group organized under the auspices of the World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Health
Chairpersons :
Jean-Marc Kaufman
& René Rizzoli
- Screening, diagnosis and identification of patients to be treated
- Outcomes of a new meta-analysis assessing pharmacological treatments in osteoporosis in men
- Recommendations from ESCEO: GRADE assessment
14:00 - 15:00
Room 118
ESCEO and IOF guidance for the conduct and reporting of Real-World Evidence studies in osteoporosis
Chairpersons :
Nicholas Harvey
& Andrea Laslop
- Real World Evidence: a critical new approach for pharmaceutical regulation
- State-of-the-art epidemiology for Real World Evidence
- Real World Evidence: the future of research in osteoporosis?
- Q/A-Panel discussion: René Rizzoli (leader), Andrea Laslop, Daniel Prieto Alhambra, Peyman Hadji, Nicholas Harvey
14:00 - 15:00
Room 130
Sponsored Meet-The-Expert Session
15:00 - 17:00
Auditorium A
Scientific Session VI
Chairpersons :
Nicola Veronese
& Manju Chandran
15:00
Auditorium A
Plenary Lecture 7
Pharmacoepidemiology and big data in the post-COVID era
15:30
Auditorium A
Oral communication selected from abstracts
OC28: MUSCULOSKELETAL FUNCTIONAL ABILITY AND STRENGTH IN SUB-SAHARAN AFRICA (THE MUFASSA STUDY): DETERMINING SARCOPENIA PREVALENCE IN SOUTH AFRICA, THE GAMBIA AND ZIMBABWE
Presenting author:
Authors:
15:40
Auditorium A
Oral communication selected from abstracts
OC29: TREATMENT PERSISTENCE OF JANUS-KINASE (JAK) INHIBITORS IN RHEUMATOID ARTHRITIS AND THE EFFECT ON GLUCOCORTICOIDS USAGE AND THE IMPACT OF COMEDICATION OF CONVENTIONAL DMARDS ON TREATMENT PERSISTENCE: RETROSPECTIVE STUDY IN THE AUSTRALIAN POPULATION
Presenting author:
Authors:
15:50
Auditorium A
Oral communication selected from abstracts
OC30: INTEGRATING POST-FRACTURE CARE INTO THE PRIMARY CARE SETTING (INTERFRACT): A MIXED-METHODS STUDY TO CO-DESIGN A CARE PROGRAM TO IMPROVE RATES OF OSTEOPOROSIS AND FRACTURE TREATMENT
Presenting author:
Authors:
16:00
Auditorium A
Oral communication selected from abstracts
OC31: A DEEP LEARNING, COMPUTER VISION APPROACH TO SEGMENTATION OF BONE MICROARCHITECTURE HIGHLIGHTS THE ROLE OF THE TRABECULAR COMPARTMENT IN FRACTURE DISCRIMINATION
Presenting author:
Authors:
16:10
Auditorium A
Oral communication selected from abstracts
OC32: EVALUATING THE DIAGNOSTIC VALUE OF AN AUTOMATIC IMAGE ANALYSES SYSTEM FOR OSTEOPOROSIS AND SARCOPENIA IN OLDER MEN: MROS STUDY
Presenting author:
Authors:
16:20
Auditorium A
Oral communication selected from abstracts
OC33: DISORGANIZED BONE COMPONENTS: A NOVEL BIOMARKER UNRELATED TO BONE DENSITY AND STRUCTURE THAT MAY HOLD THE KEY TO THE DIAGNOSIS OF ATYPICAL OR STRESS FRACTURES
Presenting author:
Authors:
16:30
Auditorium A
Plenary Lecture 8
Hopes and disappointments of new and emerging OA therapies
15:00 - 16:45
Room 131-132
Committee of Scientific Advisors Special Session
Osteoporosis state-of-the-art from the IOF Committee of Scientific Advisors
Chairpersons :
Nicholas Harvey
& Serge Ferrari
- Advances in HRpQCT – from novel phenotypes to improved fracture risk prediction
- Antiresorptives and dental implant healing-a global consensus statement
- Musculoskeletal ageing-a global perspective
Sunday May 7th - CEST Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 130
Psoriatic disease. New therapeutic horizons and the effect on the musculoskeletal system in the era of COVID-19
Chairperson :
Athanassiou Panagiotis
- Psoriatic disease in the era of COVID-19
- Psoriatic disease. Comorbidities
- Psoriatic disease and rehabilitation
- Psoriatic disease. New therapeutic horizons. Small molecule inhibitors, biologic agents and JAK inhibitors
08:00
Room 129
Tobacco harm reduction and bone health
Chairpersons :
Maria Luisa Brandi
& Umberto Tarantino
- Cigarette smoke and bone disorders
- Health lifestyles and bone health: the Case of Tobacco Harm Reduction
- Role of cigarette smoke and tobacco heated products on bone remodeling
08:00
Room 123
Fracture Liaison Service: From Zero to Hero – National experience
Chairpersons :
Yasser El Miedany
& Mathias Toth
- Closing the treatment gap
- How pharmaceutical industry can support national FLS
- Falls: raising awareness through HCP education
08:00
Room 121
Evidence based Latin American guidelines about prevention, diagnosis and treatment of glucocorticoid induced osteoporosis. An update
Chairpersons :
Osvaldo Daniel Messina
& Claudia Campusano
- Guidelines methodology
- Results
- Panel proposal for pharmacological therapies according to fracture risk stratification
08:00
Room 119
Osteoimmunology in the era of COVID-19
Chairperson :
Kostoglou-Athanassiou Ifigenia
- Pandemics through the ages. The role of stress trauma and frailty
- Menopause and osteoimmunology
- Osteoimmunology and current treatment of osteoporosis
- Osteoimmunology. The connection between bone and the immune system
08:00
Room 120
The Current and Future Approaches in the Diagnosis and Management of Sarcopenia
Chairpersons :
Pınar Borman
& Belgin Karaoglan
- What is sarcopenia? How is it diagnosed?
- Sarcopenia and New Biomarkers.
- The Management of Sarcopenia
08:00
Room 122
Update in Musculoskeletal Conditions with Hand involvement
Chairpersons :
Fitnat Dincer
& Andreas Winkelmann
- Degenerative joint disease of Hand, Osteoarthritic Hand
- Hand involvement in Complex Regional Pain Syndrome-CRPS (Sudeck atrophy, osteoporosis in hand)
- Soft tissue lesions / non articular involvement of Hand
08:00 - 09:00
Room 131-132
ESCEO SYMPOSIUM
Update on the role of oral Bisphosphonates in the treatment of osteoporosis
Chairpersons :
Jean-Marc Kaufman
& René Rizzoli
- Risk/benefit ratio of oral Bisphosphonates in the treatment of osteoporosis (fracture reduction, GI, CV, AFF, ONJ,…)
- New formulation of oral Bisphosphonates: Impact on the reduction of osteoporosis treatment gap
- Discussion
08:00 - 09:00
Room 118
SICOT-ESCEO-IOF Symposium
Standards in Management of Osteoporotic Fractures
Chairperson :
Ilir Hasani
- Management of Osteoporotic Spinal Fractures
- Treatment of unstable osteoporotic bimalleolar ankle fractures
- Management of Acetabular fractures in elderly
- Proximal femur fractures in elderly
09:00 - 10:00
Meet-The-Expert Session
09:00
Room 122
Complex cases – questions and answers
09:00
Room 123
High bone mass: what should we do?
09:00
Room 119
Transgender medicine and bone
09:00
Room 120
Dietary patterns and bone health
09:00 - 10:00
Poster Area
Poster Viewing Session III
09:00 - 10:00
Room 130
Educational Lecture organized by OAFI
The beneficial effects of pharmaceutical-grade chondroitin sulfate on cardiovascular system in patients with osteoarthritis
09:00 - 10:00
Room 118
Sponsored Meet-The-Expert Session
10:00 - 12:00
Auditorium A
Scientific Session VII
Chairpersons :
Adolfo Diez-Perez
& Radmila Matijevic
10:00
Auditorium A
Plenary Lecture 9
Do high and very high fracture risk really matter?
10:30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium A
Oral communication selected from abstracts
OC34: LONG-TERM SAFETY OF BUROSUMAB IN ADULTS WITH X-LINKED HYPOPHOSPHATAEMIA (XLH) IN A PHASE 3B OPEN-LABEL STUDY
Presenting author:
Authors:
10:50
Auditorium A
Oral communication selected from abstracts
OC35: HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH TUMOR-INDUCED OSTEOMALACIA: REVIEW OF PATIENT HISTORIES PRIOR TO ENTRY IN CLINICAL TRIAL UX023T-CL201
Presenting author:
Authors:
11:00
Auditorium A
Oral communication selected from abstracts
OC36: A DIETARY PLUS EXERCISE INTERVENTION IMPROVES BONE TURNOVER IN PATIENTS WITH METABOLIC SYNDROME AND TYPE 2 DIABETES
Presenting author:
Authors:
11:10
Auditorium A
Oral communication selected from abstracts
OC37: INTEGRATED LONG-TERM BONE MINERAL DENSITY OUTCOMES IN WOMEN RECEIVING RELUGOLIX COMBINATION THERAPY IN LIBERTY AND SPIRIT STUDIES VS NON-TREATED WOMEN
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC38: ZOLEDRONATE AS A PREVENTATIVE MEASURE FOR BONE LOSS FOLLOWING DENOSUMAB DISCONTINUATION: RESULTS FROM A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL
Presenting author:
Authors:
11:30
Auditorium A
Plenary Lecture 10
Management of premenopausal osteoporosis
12:00 - 13:00
Non-Sponsored Symposia
12:00
Room 122
Perioperative bone optimization in the arthroplasty candidate
Chairperson :
Roberto Enrique Lopez Cervantes
- State of the art. What do we know about bone density after arthroplasty?
- The Effect of Antiresorptive on Bone Loss After Arthroplasty. Literature Review and Meta-Analysis of Randomized Controlled Trials
- Periprosthetic BMD loss and its implication in the revision and complication rates
- Statement position proposal of how to do "bone optimization in the arthroplasty candidate"
12:00
Room 123
Link between diabetes, osteoporosis and bone health - rheumatologist, endocrinologist and registered dietitian point of view
Chairperson :
Mislav Radić
- Osteoporosis and bone health in diabetes mellitus
- Nutrition and bone health in diabetes-induced osteoporosis
- Bone health and osteoporosis treatment in diabetes mellitus
12:00
Room 120
Bone health and cancer: A dicey duo
Chairpersons :
Yasser El Miedany
& Naglaa Gadallah
- Addressing Bone Loss in Cancer patients: A step forward
- What Treating Doctors and Breast Cancer Survivors Need to Know About Osteoporosis
- Optimal bone health management strategies in patients with prostate cancer
- Bone health in childhood cancer
12:00
Room 130
Prevention of osteoporotic fractures: the role of exercise and of FRID (falls risk increasing drugs) avoidance
Chairperson :
Ana Paula Barbosa
- The role of post-fracture exercise in women´s physical function and quality of life
- The role of FRID (Falls Risk Increasing Drugs) avoidance
- Q&A
12:00
Room 129
Sarcopenia and rheumatoid arthritis
Chairpersons :
Kostoglou-Athanassiou Ifigenia
& Yannis Dionyssiotis
- Rheumatoid arthritis and muscular involvement
- Sarcopenia and rheumatoid arthritis
- Treatment of sarcopenia in rheumatoid arthritis
12:00
Room 119
Musculoskeletal Functional Capacity in Sub-Saharan Africa
Chairperson :
Ayse Zengin
- Co-morbidities of muscle function in older adults from The Gambia
- Impact of HIV on midlife musculoskeletal health in sub-Saharan Africa
- Markers of low muscle mass and function: insights from proteomics in middle-aged South Africans
- Muscle and functional ability in sub-Saharan Africa: The MUFASSA study
12:00
Room 121
Rare Bone Diseases: A view from LATAM
Chairperson :
Alejandro Román-González
- Welcome and general overview of rare bone diseases in Latin America
- X-LINKED hypophosphatemia (XLH): Diagnosis and treatment in adults
- Transition of care: From childhood to adulthood. How can we improve the care of our patients with endocrine disorders?
- Tumor-induced osteomalacia and fibrodysplasia ossificans progressiva in Colombia and Latin America
- Questions and wrap-up